Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADC Therapeutics SA | 144,043 | reported | 13 Jun 2025 | tx 4+80,000−4,021 |
| Pharvaris N.V. | 5,500 | reported | 21 May 2026 | tx 1−9,667 |
| DBV Technologies S.A. | 5,000 | reported | 10 Jun 2021 | tx 1+5,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | SALE | Pharvaris N.V. | 9,667 | 30.29 USD | |
| 13 Jun 2025 | TAX_WITHHOLDING | ADC Therapeutics SA | 2,584 | 3.58 USD | |
| 03 Jun 2025 | GRANT_AWARD | ADC Therapeutics SA | 40,000 | 0.00 USD | |
| 17 Jun 2024 | SALE | ADC Therapeutics SA | 1,437 | 2.89 USD | |
| 13 Jun 2024 | GRANT_AWARD | ADC Therapeutics SA | 40,000 | 0.00 USD | |
| 10 Jun 2021 | PURCHASE | DBV Technologies S.A. | 5,000 | 7.12 USD | deriv |